Table 1—

Clinical, biochemical characteristics, and results of brachial artery studies in both control subjects and patients with IFG before and 6 months after exercise training

IFG before interventionIFG after interventionControl subjects
n302230
Age (years)63.0±1263.6±1065±11
BMI (kg/m2)25.65±1.2525.07±0.9425.23±1.12
Fasting plasma glucose (mg/dl)123.7±1.14*102.3±1.2692.67±1.31
HbA1c (%)5.74±0.165.68±0.145.51±0.25
Fasting serum insulin (mU/l)8.83±1.257.92±1.647.42±1.59
Mean arterial pressure (mmHg)104±6101±8106±5
Family history (positive/negative)10/20*8/14*2/28
Total cholesterol (mmol/l)5.44±0.315.25±0.335.12±0.26
LDL cholesterol (mmol/l)3.33±0.21*2.74±0.262.46±0.20
HDL cholesterol (mmol/l)1.21±0.14*1.52±0.161.62±0.14
Triglycerides (mmol/l)1.78±0.801.53±0.611.42±0.64
Apolipoprotein A1 (g/l)1.20±0.211.22±0.221.35±0.31
Apolipoprotein B (g/l)1.35±0.171.28±0.191.13±0.14
Lipoprotein (a) (mg/l)164±62157±60147±56
C-reactive protein (mg/l)0.26±0.14*0.17±0.150.15±0.13
Vo2max (ml · kg−1 · min−1)27.4±2.332.8±2.529.3±2.1
Baseline vessel (mm)3.76±0.613.73±0.523.75±0.46
Baseline flow (ml/min)84.55±34.7185.12±32.8583.79±40.13
Flow-mediated dilation (%)3.96±0.274.86±0.244.72±0.20
GNT-induced dilation (%)20.34±1.7221.38±1.3621.85±1.18
  • Data are means ± SD.

  • *

    * P < 0.05 compared with control group;

  • P < 0.05 compared with IFG before exercise training. GNT, glyceryltrinitrate.